What This Means
This research describes the design of a clinical trial called the HOEPA study, which aims to understand how being exposed to both high temperatures and air pollution (specifically ozone) at the same time affects heart and metabolic health. Climate change is making extreme heat more common and may also worsen ozone pollution, but scientists do not yet fully understand how these two environmental stressors work together to harm the body, or whether nutritional supplements might protect against these harms. The study will expose 48 healthy adults to ozone (at 200 parts per billion) in a warm environment (32°C) in a carefully controlled chamber setting, and measure a range of heart and blood-related outcomes including blood clotting time, blood vessel function, and markers of inflammation and oxidative stress.
Half of the participants will take a fish oil supplement (eicosapentaenoic acid, or EPA, at 3 grams per day) for four weeks before the exposure, while the other half will take a placebo (corn oil). Neither participants nor researchers will know who received which treatment until the study is complete. Blood samples will be used to verify that participants actually absorbed the EPA supplement, and a washout period will allow researchers to track how long the supplement's effects last. The main measurement of interest is activated partial thromboplastin time, a measure of how quickly blood clots, which reflects cardiovascular risk.
This research suggests that omega-3 fatty acid supplementation might offer a practical, individual-level way to protect people from the heart and metabolic harms caused by combined heat and air pollution exposure. If the hypothesis is confirmed, it could have important implications for protecting vulnerable populations during extreme heat events and periods of high air pollution, which are expected to become more frequent with climate change. The study protocol itself represents a methodological contribution, offering a rigorous framework for testing environmental health interventions in controlled human exposure settings.